Summary of Conference Call Records Industry Overview: Power Equipment Key Points on Domestic and International Demand - The acceleration of ultra-high voltage (UHV) project approvals is expected, with multiple AC lines approved in the second half of the year, significantly higher than the first half. The total investment for the Shaanxi to Henan and Nanjing to Sichuan projects exceeds 30 billion yuan [1] - The investment budget for distribution networks is projected to grow by approximately 5% in 2025, focusing on smart technology, replacement of old equipment, and energy-saving renovations. Investment in grid intelligence is expected to increase by 60% year-on-year [1][5] - The European power market is seeing substantial investment in grid upgrades, with the EU planning to invest 584 billion euros by 2030, with one-third for transmission and two-thirds for distribution [1][7] Core Insights and Arguments - The approval of UHV projects is expected to increase from 2-3 AC lines in 2024 to 4-5 in 2025, indicating a significant growth trajectory [4] - The regional joint procurement in the distribution network sector has pressured the gross margins of leading companies by about 10 percentage points, but it has also increased market share for companies like XJ Electric, Samsung Medical, and Oriental Electronics [5] - The demand for low-voltage transformers and UHV equipment in Europe is rising, with Chinese manufacturers having advantages in conversion efficiency and power density [8] Company-Specific Developments - **Pinggao Electric**: New order growth of approximately 15% in the first half of 2025, with a significant increase in UHV GIS delivery expected from 2026 [11] - **China XD Electric**: Improved gross margins through cost management, with a projected delivery of 30-40 billion yuan in UHV projects for the year [12] - **XJ Electric**: Anticipates a significant increase in delivery volume for UHV products in 2026, with current orders exceeding 3 billion yuan [13] - **Siyuan Electric**: Actively expanding in the North American data center market, with a projected net profit growth of about 30% for 2025 [15] - **Samsung Medical**: Achieved a 124% year-on-year increase in overseas distribution network orders, with a projected net profit growth of 10-15% [16] - **Huaming Equipment**: European market contributes 50% of overseas revenue, with a projected net profit growth of about 15% [17] - **Guodian NARI**: Strong performance in the low-carbon energy sector, with expected revenue growth of 14-15% [18] - **Sifang Co.**: Domestic business exceeded expectations, with a 15% growth in main network orders [19] Other Important Insights - The focus on smart grid investments is expected to reshape the competitive landscape in the distribution network sector, benefiting leading companies in the medium term [5] - The North American market is experiencing tight supply for transformers and switches, creating significant opportunities for domestic companies [9] - The overall trend in the power equipment industry indicates a shift towards intelligent and sustainable solutions, aligning with global energy transition goals [10]

Core Viewpoint - Samsung Medical (601567.SH) has developed an integrated solution in the field of smart energy management to meet the needs of domestic and international customers [1] Group 1 - The company has formed a comprehensive solution in smart power distribution, which includes smart meters, smart terminals, communication modules, system software, transformers, box-type substations, switch cabinets, power boxes, photovoltaic/wind power box transformers, charging piles, inverters, and energy storage-related products [1] - Currently, the company does not have any military-related business [1]

Core Viewpoint - Samsung Medical (601567.SH) has developed an integrated solution in the field of smart energy management to meet the needs of domestic and international customers, which includes various products and systems [1] Group 1 - The company has formed a comprehensive solution in smart power distribution, which encompasses smart meters, smart terminals, communication modules, system software, transformers, box-type substations, switch cabinets, power boxes, photovoltaic/wind power box transformers, charging piles, inverters, and energy storage-related products [1] - Currently, the company does not have any military-related business [1]

Core Viewpoint - Samsung Medical (601567.SH) is leveraging its advantages in the power grid channel to actively secure new clients in the petrochemical and data center sectors, aiming for significant breakthroughs by the first half of 2025 [1] Group 1 - The company has achieved breakthroughs in new client areas such as petrochemicals and data centers, securing orders worth tens of millions [1] - Currently, there is no active collaboration with these new clients, and further details will be provided in company announcements [1]

Group 1 - The company has been recommended as a candidate for the bid in the first batch of metering equipment framework tender project by China Southern Power Grid Company for 2025, with an expected bid amount of approximately 274.33 million yuan [1] - The main content of the project includes various types of smart energy meters and communication modules, indicating a diverse product offering [1] - The expected bid amount of 274.33 million yuan is based on the company's bid quantity and pricing calculations, which will positively impact the company's operational performance and business results [1] Group 2 - The company has not yet received the official bid notification from China Southern Power Grid Company, and the contract duration will be determined based on actual contract requirements, introducing uncertainty regarding the impact on the company's performance [2]

Group 1 - Samsung Medical announced that it has been recommended as a candidate for the first batch of metering equipment framework bidding project by the Southern Power Grid Company for 2025 [2] - The expected bid amount is approximately 274.33 million yuan [2]

Core Insights - The 2025 mid-year reports for listed instrument companies show a mixed performance, with 40 out of 50 companies reporting revenue growth, while 34 companies reported an increase in net profit [1][4][5] - Significant disparities in performance exist among companies, with some experiencing substantial profit growth while others face severe declines [3][7][9] Revenue Performance - Total revenue for the 50 listed instrument companies reached approximately 65.965 billion, with 40 companies showing revenue growth, and 14 companies achieving growth rates above 20% [1][4] - Companies with revenues exceeding 1 billion include: - 汇川技术 (Hui Chuan Technology) 20.509 billion - 三星医疗 (Samsung Medical) 7.972 billion - 川仪股份 (Chuan Yi Co.) 3.281 billion - 华测检测 (Hua Ce Testing) 2.96 billion - 科陆电子 (Ke Lu Electronics) 2.573 billion [5] Profit Performance - Total net profit for the 50 companies was approximately 8.735 billion, with 34 companies reporting profit growth, and 10 companies achieving growth rates above 50% [1][4] - Companies with net profits exceeding 1 billion include: - 汇川技术 (Hui Chuan Technology) 2.968 billion - 三星医疗 (Samsung Medical) 1.230 billion [5] Notable Performers - High performers include: - 高德红外 (Gao De Infrared) with a net profit growth of 906.85% and revenue growth of 68.24% [6] - 汇中股份 (Hui Zhong Co.) with a net profit growth of 102.72% and revenue growth of 51.67% [5] - 科陆电子 (Ke Lu Electronics) with a net profit growth of 579.14% [5] Underperformers - Companies facing significant declines include: - 聚光科技 (Ju Guang Technology) with a net profit decline of 210.86% [7] - 秦川物联 (Qin Chuan IoT) with a net profit decline of 209.73% [7] - 万讯自控 (Wan Xun Control) with a net profit decline of 253.92% [7] - 蓝盾光电 (Lan Dun Optoelectronics) with a net profit decline of 1877.03% [7] Market Trends - The performance disparity among companies is expected to continue, although overall A-share profitability may improve marginally due to supportive macroeconomic policies [9]

证券代码：601567 证券简称：三星医疗 公告编号：临 2025-072 根据公示内容，公司为此项目A级单相智能电能表、B级三相智能电能表、C级三 相智能电能表、A级单相智能网关电能表、B级三相智能网关电能表、C级三相智能网 关电能表、智能量测终端（公变型）、负荷管理终端、智能量测终端（专变型）、宽 带双模通信模块的中标候选人。依据公司预中标数量以及报价测算，预计中标金额约 为27,433.36万元。 本次预中标公示媒体是中国南方电网供应链统一服务平台，招标人是中国南方电 网有限责任公司，其他详细内容请查看中国南方电网网站公示： https://www.bidding.csg.cn/zbhxrgs/1200405717.jhtml 二、预中标项目对公司业绩的影响 宁波三星医疗电气股份有限公司 关于经营合同预中标的提示性公告 本公司董事会及全体董事保证公告内容不存在虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 宁波三星医疗电气股份有限公司（以下简称"公司"）于近日在南方电网公司2025 年计量设备第一批框架招标项目中被推荐为中标候选人，预计中标金额约为27,433.36 ...

Group 1 - The company, Samsung Medical (601567.SH), has been recommended as a candidate for winning the first batch of framework bidding for metering equipment by the Southern Power Grid Company for 2025, with an expected bid amount of approximately 274 million yuan [1] - The project includes various categories such as Class A single-phase smart electric meters and Class B three-phase smart electric meters [1] - The fulfillment of the contract is expected to have a positive impact on the company's operating performance, although the specific amount and timing remain uncertain [1]

Group 1 - Samsung Medical (601567) announced on September 2 that it has been recommended as a candidate for the first batch of framework bidding projects for metering equipment by the Southern Power Grid Company for 2025 [1] - The expected bid amount for the project is approximately 274 million yuan [1]